Liquid Biopsies: Using Blood Tests to Detect Cancer Recurrence
Canadian researchers are developing high-sensitivity liquid biopsies—blood tests that detect circulating tumor DNA (ctDNA)—to identify minimal residual disease (MRD) after cancer treatment. By spotting molecular traces of tumors before they ... Read More